These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Design, asymmetric synthesis, and evaluation of pseudosymmetric sulfoximine inhibitors against HIV-1 protease. Lu D; Sham YY; Vince R Bioorg Med Chem; 2010 Mar; 18(5):2037-48. PubMed ID: 20138769 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel isopropanolamine derivatives as non-peptide human immunodeficiency virus protease inhibitors. Zhou L; Yang Q; Wang Y; Hu Y; Luo X; Bai D; Li S Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1147-52. PubMed ID: 18670116 [TBL] [Abstract][Full Text] [Related]
16. New anti-HIV derivatives: synthesis and antiviral evaluation. De Michelis C; Rocheblave L; Priem G; Chermann JC; Kraus JL Bioorg Med Chem; 2000 Jun; 8(6):1253-62. PubMed ID: 10896105 [TBL] [Abstract][Full Text] [Related]
17. Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. Rodgers JD; Lam PY; Johnson BL; Wang H; Li R; Ru Y; Ko SS; Seitz SP; Trainor GL; Anderson PS; Klabe RM; Bacheler LT; Cordova B; Garber S; Reid C; Wright MR; Chang CH; Erickson-Viitanen S Chem Biol; 1998 Oct; 5(10):597-608. PubMed ID: 9818151 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus. Raghavan S; Lu Z; Beeson T; Chapman KT; Schleif WA; Olsen DB; Stahlhut M; Rutkowski CA; Gabryelski L; Emini E; Tata JR Bioorg Med Chem Lett; 2007 Oct; 17(19):5432-6. PubMed ID: 17692518 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and QSAR studies on thiazolidinones as anti-HIV agents. Rawal RK; Solomon VR; Prabhakar YS; Katti SB; De Clercq E Comb Chem High Throughput Screen; 2005 Aug; 8(5):439-43. PubMed ID: 16101583 [TBL] [Abstract][Full Text] [Related]